The Oncidium Foundation was created in 2011 to promote the development of nuclear medicine therapy through the dissemination of reliable and complete information for patients. Radiotherapeutics and radiotheranostics represent a new class of drugs that can be used for patient suffering from incurable cancers. The Foundation's priority include promoting the awareness among patients and physicians, investing in research and scholarship, supporting and financing the development of new radiopharmaceuticals for therapy, supporting clinical best practice and improving access to patients.